Sino-Argi Leading Biosciences (SHG:603970) — Market Cap & Net Worth
Market Cap & Net Worth: Sino-Argi Leading Biosciences (603970)
Sino-Argi Leading Biosciences (SHG:603970) has a market capitalization of $405.14 Million (CN¥2.77 Billion) as of August 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #13362 globally and #3956 in its home market, demonstrating a 2.59% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sino-Argi Leading Biosciences's stock price CN¥10.30 by its total outstanding shares 268800134 (268.80 Million). See 603970 capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Sino-Argi Leading Biosciences Market Cap History: 2017 to 2026
Sino-Argi Leading Biosciences's market capitalization history from 2017 to 2026. Data shows growth from $642.52 Million to $405.14 Million (2.81% CAGR).
Sino-Argi Leading Biosciences Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sino-Argi Leading Biosciences's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Sino-Argi Leading Biosciences's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.93x
Sino-Argi Leading Biosciences's market cap is 2.93 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $642.52 Million | $3.50 Billion | $90.33 Million | 0.18x | 7.11x |
| 2018 | $332.26 Million | $3.73 Billion | $115.46 Million | 0.09x | 2.88x |
| 2019 | $337.65 Million | $4.34 Billion | $118.88 Million | 0.08x | 2.84x |
| 2020 | $562.16 Million | $6.64 Billion | $132.44 Million | 0.08x | 4.24x |
| 2021 | $704.19 Million | $8.82 Billion | $170.31 Million | 0.08x | 4.13x |
| 2022 | $800.59 Million | $11.70 Billion | $210.32 Million | 0.07x | 3.81x |
| 2023 | $604.17 Million | $10.46 Billion | $224.84 Million | 0.06x | 2.69x |
| 2024 | $558.54 Million | $10.60 Billion | $203.38 Million | 0.05x | 2.75x |
| 2025 | $505.83 Million | $11.24 Billion | $172.53 Million | 0.04x | 2.93x |
Competitor Companies of 603970 by Market Capitalization
Companies near Sino-Argi Leading Biosciences in the global market cap rankings as of August 7, 2026.
Key companies related to Sino-Argi Leading Biosciences by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #516 globally with a market cap of $51.69 Billion USD.
- Nutrien Ltd (TO:NTR): Ranked #833 globally with a market cap of $32.51 Billion USD ( CA$44.94 Billion CAD).
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1179 globally with a market cap of $22.09 Billion USD ( CN¥150.97 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1493 globally with a market cap of $16.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Corteva Inc | NYSE:CTVA | $51.69 Billion | $76.86 |
| #833 | Nutrien Ltd | TO:NTR | $32.51 Billion | CA$93.62 |
| #1179 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $22.09 Billion | CN¥28.53 |
| #1493 | CF Industries Holdings Inc | NYSE:CF | $16.81 Billion | $116.73 |
Sino-Argi Leading Biosciences Historical Marketcap From 2017 to 2026
Between 2017 and today, Sino-Argi Leading Biosciences's market cap moved from $642.52 Million to $ 405.14 Million, with a yearly change of 2.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥405.14 Million | -19.91% |
| 2025 | CN¥505.83 Million | -9.44% |
| 2024 | CN¥558.54 Million | -7.55% |
| 2023 | CN¥604.17 Million | -24.53% |
| 2022 | CN¥800.59 Million | +13.69% |
| 2021 | CN¥704.19 Million | +25.27% |
| 2020 | CN¥562.16 Million | +66.49% |
| 2019 | CN¥337.65 Million | +1.62% |
| 2018 | CN¥332.26 Million | -48.29% |
| 2017 | CN¥642.52 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 7th, 2026 the market cap of Sino-Argi Leading Biosciences was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $405.14 Million USD |
| MoneyControl | $405.14 Million USD |
| MarketWatch | $405.14 Million USD |
| marketcap.company | $405.14 Million USD |
| Reuters | $405.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sino-Argi Leading Biosciences
Sino-Agri Leading Biosciences Co.,Ltd engages in pesticide distribution in China and internationally. The company sells technical materials, formulations, and related products. It also provides plant protection technology services; and crop health solutions, including technical guidance, application demonstration, and processing and packaging of plant protection products. In addition, the company… Read more